Moonwalk Biosciences

SOUTH SAN FRANCISCO, CA · Founded 2022 · CIK 0002004362 · Biotech · Private

Cell reprogramming platform targeting the epigenetic code to restore healthy cellular states

moonwalk.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$110M
2 Form D · Sep 2026
1 months since last filing
Contracts
—
No federal contracts on record
Patents
11
0 granted · 11 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$49,574,983
Private capital raisedForm D · SEC$59,999,998
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1515REPLICEL LIFE SCIENCES INC.—$5.8M
1516Ideaya Biosciences, Inc.—$111M
1517Virscio Inc——
1518Moonwalk Biosciences—$110M
1519DEGROME THERAPEUTICS, INC.——
1520Bell Biosystems, Inc.—$2.4M
1521MOSAIC ENGINEERING LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Alexander AravanisDirector · Executive Officer
  • Arash JamshidiDirector · Executive Officer
  • Justin ValleyExecutive Officer

Patents

USPTO · 0 granted of 11
  • Methods And Systems For Long-range Methylation Profilingapplication
  • Methods And Compositions For Modifying Nucleotide Sequencesapplication
  • Methods And Systems For Long-range Methylation Profilingapplication
  • Generation And Use Of Epigenetic Maps For Drug Discoveryapplication
  • Generation And Use Of Epigenetic Maps For Drug Discoveryapplication
  • Controlled Reprogramming Of A Cellapplication
  • Methods For Cellular Transdifferentiation Through Direct Epigenetic Editingapplication
  • Methods And Compositions For Modifying Nucleotide Sequencesapplication
  • Methods And Systems For Long-range Methylation Profilingapplication
  • Methods For Partial Cellular Reprogrammingapplication
  • Controlled Partial Reprogramming Of A Cellapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.